THCA 16.4%. THC 0.97%. CBDA 0.033%. CBD 0.166%. CBGA 0.73%. CBG 0.29%. THCV 0.43%. LABEL TOTALS: THC 14.1% CBD 0.179%.
The cannabinoid analysis reveals a THC dominant strain with little CBD and abundant CBG also showing THCV present. No terpene analysis was performed, but historically this strain is pinene dominant with humulene and myrcene as secondary. This strain would be a good choice for patients with lung and other cancers, COPD, arthritis, Parkinson’s Disease, multiple sclerosis and other neurodegenerative conditions. The THCV should moderate some of the effects of THC and make it better tolerated by new users and those in whom THC makes anxious.